Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real
- 31 January 2011
- journal article
- review article
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 41 (1), 126-139
- https://doi.org/10.1016/j.jpainsymman.2010.04.021
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Central and peripheral nervous system toxicity of common chemotherapeutic agentsCancer Chemotherapy and Pharmacology, 2008
- Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshopAnnals of Oncology, 2007
- Evaluation of Cognitive Function Associated With Chemotherapy: A Review of Published Studies and Recommendations for Future ResearchJournal of Clinical Oncology, 2007
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivoJournal of Biology, 2006
- Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancerMutation research. Reviews in mutation research, 2004
- Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2003
- Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literatureJournal of the International Neuropsychological Society, 2003
- Low neuropsychologic performance among adult cancer survivors treated with chemotherapy.Current Neurology and Neuroscience Reports, 2003
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences of the United States of America, 2000